Standardizing Scale-up: Insights into Producing Clinical and Commercial RNA-LNP Drug Products

Over the last few years, there was an unprecedented demand on biopharma manufacturers to produce an mRNA vaccine in an accelerated timeline. Given the considerable number of variables throughout the production workflow, new flexible and robust manufacturing solutions are required to accelerate scale-up and standardize GMP manufacturing processes.
This presentation will share:
- Insights into new platform technologies that increase efficiency to enable rapid scale-up and large-scale manufacturing of mRNA vaccines and therapeutics
- How to improve operational flexibility by expanding single-use technology to LNPs
- Strategies to increase manufacturing capacity during clinical and commercial production